miR-128-3p and miR-223-3p as Potential Biomarkers of Metabolic Dysfunction in Liver Tissue from Patients Undergoing Metabolic Bariatric Surgery.

Saved in:
Bibliographic Details
Title: miR-128-3p and miR-223-3p as Potential Biomarkers of Metabolic Dysfunction in Liver Tissue from Patients Undergoing Metabolic Bariatric Surgery.
Authors: Rodríguez R; Bariatric Surgery Unit. Department of General & Gastrointestinal Surgery, University Hospital of Salamanca-SACYL, Salamanca, Spain.; Department of Surgery, Complejo Asistencial de Ávila-SACYL, Àvila, Spain., Salete-Granado D; University of Salamanca, Salamanca, Spain.; Institute of Biomedical Research of Salamanca, Salamanca, Spain., Hernández-Cosido L; Bariatric Surgery Unit. Department of General & Gastrointestinal Surgery, University Hospital of Salamanca-SACYL, Salamanca, Spain.; University of Salamanca, Salamanca, Spain.; Institute of Biomedical Research of Salamanca, Salamanca, Spain., Morán MTC; University of Salamanca, Salamanca, Spain., Blanco O; University of Salamanca, Salamanca, Spain.; Institute of Biomedical Research of Salamanca, Salamanca, Spain.; Pathology Department, University Hospital of Salamanca, Salamanca, Spain., Matesanz N; Department of Vascular Biology and Inflammation, Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III,, Madrid, Spain., Rueda-Cala V; Institute of Biomedical Research of Salamanca, Salamanca, Spain.; Department of Internal Medicine, University Hospital of Salamanca-SACYL, Salamanca, Spain., Campo F; Department of Internal Medicine, University Hospital of Salamanca-SACYL, Salamanca, Spain.; University of Salamanca, Salamanca, Spain., Pérez-Nieto MÁ; University of Salamanca, Salamanca, Spain.; Foundation Institute for Health Sciences Studies of Castilla y León, Soria, Spain., Gutiérrez Cerrajero C; University of Salamanca, Salamanca, Spain.; Institute of Biomedical Research of Salamanca, Salamanca, Spain., Bernardo E; Department of Vascular Biology and Inflammation, Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III,, Madrid, Spain.; Organ Crosstalk in Metabolic Diseases Group, Molecular Oncology Program, National Cancer Centre (CNIO), Madrid, Spain., Macías R; Department of Internal Medicine, Complejo Asistencial de Zamora-SACYL, Zamora, Spain., Sabio G; Department of Vascular Biology and Inflammation, Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III,, Madrid, Spain.; Organ Crosstalk in Metabolic Diseases Group, Molecular Oncology Program, National Cancer Centre (CNIO), Madrid, Spain., Torres JL; Department of Internal Medicine, Complejo Asistencial de Zamora-SACYL, Zamora, Spain., Rojas-Pirela M; Institute of Biomedical Research of Salamanca, Salamanca, Spain. mrojaspirela@usal.es.; Department of Internal Medicine, University Hospital of Salamanca-SACYL, Salamanca, Spain. mrojaspirela@usal.es.; University of Salamanca, Salamanca, Spain. mrojaspirela@usal.es., Marcos M; Institute of Biomedical Research of Salamanca, Salamanca, Spain. mmarcos@usal.es.; Department of Internal Medicine, University Hospital of Salamanca-SACYL, Salamanca, Spain. mmarcos@usal.es.; University of Salamanca, Salamanca, Spain. mmarcos@usal.es.
Source: Obesity surgery [Obes Surg] 2026 Apr; Vol. 36 (4), pp. 1469-1483. Date of Electronic Publication: 2026 Mar 12.
Publication Type: Journal Article
Journal Info: Publisher: Springer Science + Business Media Country of Publication: United States NLM ID: 9106714 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1708-0428 (Electronic) Linking ISSN: 09608923 NLM ISO Abbreviation: Obes Surg Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1708-0428
DOI:10.1007/s11695-026-08499-3